---
figid: PMC6317881__nihms-999163-f0006
figtitle: Interactions of genes involved in tumor progression and EMT
organisms:
- NA
pmcid: PMC6317881
filename: nihms-999163-f0006.jpg
figlink: /pmc/articles/PMC6317881/figure/F6/
number: F6
caption: Potential interactions of genes involved in tumor progression and EMT. A,
  Vitamin D–responsive genes (Gjb2, Mmp13, Mmp17, Efemp1, and Pdlim2) are shown interacting
  with CDH1 (E-cadherin), VIM (vimentin), TP53 (P53 tumor suppressor), Acan (aggrecan),
  Timp1 (tissue inhibitor of metalloproteinases 1), MMP2 (matrix metallopeptidase
  2), and MMP9 (matrix metallopeptidase 9). B, Non–vitamin D-responsive genes (Fscn1,
  Acp5, Ctsz, Prrx1, Nes, Fut4, Abca1, and Hoxd9) are shown interacting with CDH1,
  CDH2 (N-cadherin), VIM, ACP5 (tartrate-resistant acid phosphatase 5), BCL2 (apoptosis
  regulator), ZEB1, PCNA (proliferating cell nuclear antigen), ACTA2 (alpha-actin-2),
  MMP2, MMP9, (matrix metallopeptidase 9), MMP3, and CASP3 (caspase-3). ITG, integrins.
  The figure was generated by Pathway Studio (https://www.elsevier.com/solutions/pathway-studio-biological-research).
papertitle: Cyp24a1 Attenuation Limits Progression of BrafV600E-Induced Papillary
  Thyroid Cancer Cells and Sensitizes Them to BRAFV600E Inhibitor PLX4720.
reftext: Minjing Zou, et al. Cancer Res. 2017 Apr 15;77(8):2161-2172.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9565242
figid_alias: PMC6317881__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6317881__F6
ndex: 924e6991-de9f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6317881__nihms-999163-f0006.html
  '@type': Dataset
  description: Potential interactions of genes involved in tumor progression and EMT.
    A, Vitamin D–responsive genes (Gjb2, Mmp13, Mmp17, Efemp1, and Pdlim2) are shown
    interacting with CDH1 (E-cadherin), VIM (vimentin), TP53 (P53 tumor suppressor),
    Acan (aggrecan), Timp1 (tissue inhibitor of metalloproteinases 1), MMP2 (matrix
    metallopeptidase 2), and MMP9 (matrix metallopeptidase 9). B, Non–vitamin D-responsive
    genes (Fscn1, Acp5, Ctsz, Prrx1, Nes, Fut4, Abca1, and Hoxd9) are shown interacting
    with CDH1, CDH2 (N-cadherin), VIM, ACP5 (tartrate-resistant acid phosphatase 5),
    BCL2 (apoptosis regulator), ZEB1, PCNA (proliferating cell nuclear antigen), ACTA2
    (alpha-actin-2), MMP2, MMP9, (matrix metallopeptidase 9), MMP3, and CASP3 (caspase-3).
    ITG, integrins. The figure was generated by Pathway Studio (https://www.elsevier.com/solutions/pathway-studio-biological-research).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACAN
  - GJB2
  - TP53
  - VIM
  - EFEMP1
  - CDH1
  - FZR1
  - PDLIM2
  - GAPDH
  - GAPDHP44
  - TIMP1
  - MMP17
  - MMP13
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP14
  - MMP15
  - MMP16
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - ACP5
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - FUT4
  - CTSZ
  - PCNA
  - BCL2
  - NES
  - ZEB1
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - CASP3
  - CDH2
---
